Cornea/External Disease News

The color of a blue iris is not produced by so-called pigment coloring — the simple form of selective color absorption that produces the hue of everyday objects like blueberries or blue jeans.

Lipid-based eye drops may help treat evaporative dry eye disease, although additional research, particularly with placebo-controlled study designs, is needed, according to a review.

Okyo Pharma released new data from its phase 2 trial of OK-101, a lipid conjugated chemerin peptide agonist, which showed a 68% improvement in both conjunctival staining and ocular pain among patients with dry eye disease.

More research is needed to improve diagnosis of dry eye disease in children, as well as to determine the safety and efficacy of treatment options in this population, according to a literature review published in The Ocular Surface.

Although similarities exist between ocular graft-versus-host disease and dry eye disease, more research is needed to improve diagnostic criteria and treatment, according to a review in Clinical & Experimental Ophthalmology.

The Twin Cities Ocular Surface Disease Symposium, Sept. 7 and 8, will feature discussions about dry eye comorbidities, standards of care and more, Ahmad M. Fahmy, OD, FAAO, DiplABO, the event’s founder, told Healio.

A dexamethasone 0.4 mg intracanalicular insert was linked to greater improvement in corneal and conjunctival staining vs. a sham collagen plug among patients with aqueous-deficient dry eye, although it may increase IOP, research showed.

Topline results from the phase 2b RELIEF trial demonstrate that licaminlimab has the potential to reshape the treatment paradigm of dry eye disease, offering a more precise strategy than current methods.

For the fourth consecutive year, Prevent Blindness has declared June 28 to July 4 as Fireworks Safety Awareness Week, a time to educate the public about the dangers of fireworks.

NASHVILLE, Tenn. — Wave-guided optics application technology may now help patients with keratoconus, according to a speaker at Optometry’s Meeting.